comparemela.com

Latest Breaking News On - Cheyne capital management united kingdom - Page 17 : comparemela.com

Travere Therapeutics, Inc (NASDAQ:TVTX) Receives Consensus Recommendation of Moderate Buy from Brokerages

Travere Therapeutics, Inc (NASDAQ:TVTX) Receives Consensus Recommendation of Moderate Buy from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Xenon Pharmaceuticals Inc (NASDAQ:XENE) Shares Sold by Knott David M Jr

Knott David M Jr lessened its position in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 32.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 40,000 shares of the biopharmaceutical company’s stock after selling 19,500 shares during the quarter. Knott David M […]

StockNews com Begins Coverage on Xenon Pharmaceuticals (NASDAQ:XENE)

StockNews.com assumed coverage on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) in a research report report published on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other analysts have also commented on XENE. Cantor Fitzgerald assumed coverage on shares of Xenon Pharmaceuticals in a report on Tuesday, April […]

Heron Therapeutics (NASDAQ:HRTX) Downgraded to Sell at StockNews com

StockNews.com cut shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) from a hold rating to a sell rating in a research note published on Wednesday morning. HRTX has been the topic of several other research reports. Needham & Company LLC reiterated a buy rating and issued a $5.00 price objective on shares of Heron Therapeutics […]

Aerovate Therapeutics, Inc Expected to Earn Q3 2023 Earnings of ($0 65) Per Share (NASDAQ:AVTE)

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) – Stock analysts at Wedbush dropped their Q3 2023 earnings per share (EPS) estimates for shares of Aerovate Therapeutics in a research report issued to clients and investors on Tuesday, August 15th. Wedbush analyst A. Argyrides now expects that the company will post earnings of ($0.65) per share […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.